European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
About this item
Full title
European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2023
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Alternative Titles
Full title
European Medicines Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington’s Disease
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2779241365
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2779241365
How to access this item
Log in as a Library member